Evidence map›Paper›PMID 42485388›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Oncogenic Gα signaling requires AP-3-dependent recruitment to the endolysosomal compartment.

Megha Shettigar, Salomé Moulière, Larissa Isenegger, Alexander L DeVine, Cécile Gstalder, Vidyasagar Koduri, John G Doench, Bruce Ksander, Mikel Garcia-Marcos, William G Kaelin and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Positive selection screen identifies natural product β-catenin inactivators.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Megha ShettigarDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Salomé MoulièreDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Larissa IseneggerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Alexander L DeVineDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Cécile GstalderDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Vidyasagar KoduriDepartment of Hematology, Brigham and Women's Hospital, Boston, MA 02115.
John G DoenchGenetic Perturbation Platform, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142.ORCID 0000-0002-3707-9889
Bruce KsanderSchepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA 02114.
Mikel Garcia-MarcosDepartment of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA 02118.ORCID 0000-0001-9513-4826
William G KaelinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.ORCID 0000-0002-0574-4856
Rizwan HaqDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.ORCID 0000-0002-1290-9276

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI Irene M. Ghobrial · 1985 to 2026
$330.6M
Addressing the complexity and plasticity of heterotrimeric G protein signalingR35GM156286 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Mikel Garcia-Marcos · 2025 to 2026
$1.4M
NCI NIH HHS P30 CA006516NIGMS NIH HHS R35 GM156286
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) constitute the largest superfamily of cell-surface receptors, yet the spatial constraints governing their signaling remain poorly defined. Here, we demonstrate that Gα, an essential downstream component of GPCR signaling, undergoes a spatial shift from the plasma membrane to the endolysosomal compartment upon its constitutive activation. Using a genome-wide CRISPR screen, we identify the adaptor protein AP-3 as the essential mediator of this trafficking event. Loss of AP-3-dependent recruitment impairs Gα-driven signaling and proliferation in uveal melanoma cells harboring oncogenic Gα mutations. We further identify a highly evolutionarily conserved AP-3 binding motif in all Gα proteins, present from yeast to humans. Disrupting this site causes Gα mislocalization and potently suppresses tumor growth and metastasis in vivo. Conversely, tethering Gα to the endolysosomal membrane is sufficient to rescue oncogenic signaling. Our findings reveal that endolysosomal recruitment is a fundamental, conserved requirement for Gα activity, uncovering a spatial vulnerability that may be exploited to target dysregulated G-protein signaling in human disease.

Indexed as

Adaptor Protein Complex 3EndosomesGTP-Binding Protein alpha SubunitsLysosomesAnimalsCell Line, TumorCell MembraneHumansMelanomaMiceProtein TransportSignal TransductionUveal NeoplasmsAdaptor Protein Complex 3GTP-Binding Protein alpha SubunitsG-alphaG proteinlysosometraffickinguveal melanoma

Identifiers

PMID42485388
PMCPMC13415926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.